COO — The Cooper Companies, Inc. stock price, charts and financials

NASDAQ·Healthcare·Medical - Instruments & Supplies·USA

Latest market price

74.69

+0.46+0.62%

Overview Short InterestFilings

COOQT43The Cooper Companies, Inc.·NASDAQ

Overview Short InterestFilings

74.69+0.62%

News

Up 0.6% — Williams Companies Inc (WMB) (Q2 2026) Earnings Call Highlights: Raises Guidance and Boosts Long-Term Growth Target to 11% CAGR (gurufocus.com).

Medium confidence

Loading chart...

Screen all →

BAX+0.89%$28.35 SOLV-0.15%$87.94 AVTR+0.07%$13.68 ATR-0.43%$136.18 WST+0.24%$348.76 RGEN+1.85%$149.78 TFX+0.30%$140.12 MDLN+3.88%$42.04

Snapshot

Index	S&P 500	P/E	63.30	EPS (ttm)	1.18	Insider Own	0.61%	Shs Outstand	195.03M	Perf Week	3.65%

Market Cap	14.57B	Forward P/E	14.92	EPS next Y	5.01	Insider Trans	0.00%	Shs Float	193.67M	Perf Month	2.86%

Enterprise Value	16.89B	PEG	8.18	EPS next Q	1.11	Inst Own	-	Short Float	4.09%	Perf Quarter	21.41%

Income	236.00M	P/S	3.44	EPS this Y	292.49%	Inst Trans	-	Short Ratio	2.72	Perf Half Y	-7.39%

Sales	4.23B	P/B	1.77	EPS next Y	8.11%	ROA	1.89%	Short Interest	7.92M	Perf YTD	-8.87%

Book/sh	42.24	P/C	104.80	EPS next 5Y	7.74%	ROE	2.84%	52W High	89.83 -16.85%	Perf Year	5.39%

Cash/sh	0.71	P/FCF	24.77	EPS past 3/5Y	-1.22% -17.22%	ROIC	2.52%	52W Low	58.89 26.83%	Perf 3Y	-24.06%

Dividend Est.	0.01 (0.01%)	EV/EBITDA	19.50	Sales past 3/5Y	7.35% 10.98%	Gross Margin	64.37%	Volatility	2.02% 2.29%	Perf 5Y	-27.13%

Dividend TTM	-	EV/Sales	3.99	EPS Y/Y TTM	-39.80%	Oper. Margin	11.77%	ATR (14)	1.81	Perf 10Y	69.71%

Dividend Ex-Date	Jul 26, 2023	Quick Ratio	0.78	Sales Y/Y TTM	8.63%	Profit Margin	5.57%	RSI (14)	64.61	Recom	2.40

Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	1.27	EPS Q/Q	26.04%	SMA20	4.50%	Beta	0.81	Target Price	76.80

Payout	0.00%	Debt/Eq	0.34	Sales Q/Q	7.98%	SMA50	8.98%	Rel Volume	0.69	Prev Close	74.23

Employees	15,000	LT Debt/Eq	0.33	Earnings	Sep 09	SMA200	2.13%	Avg Volume	2.87M	Price	74.69

IPO Date	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.64% 2.63%	Net Debt/EBITDA	2.68	Volume	1,969,935	Change	0.62%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jun-05-26	Reiterated	Wells Fargo	Equal Weight	$66
Jun-05-26	Reiterated	Needham	Buy	$99 → $86
Jun-04-26	Reiterated	Mizuho	Outperform	$100 → $85
Jun-01-26	Reiterated	Piper Sandler	Overweight	$94 → $86
May-27-26	Reiterated	Goldman Sachs	Sell	$69 → $61
Feb-03-26	Reiterated	Needham	Buy	$100 → $99
Jan-26-26	Reiterated	Barclays	Overweight	$91 → $98
Jan-09-26	Reiterated	Goldman Sachs	Sell	$71 → $73
Dec-08-25	Reiterated	Barclays		$85 → $91
Dec-08-25	Reiterated	Goldman Sachs	Sell	$64 → $71

Latest News

Aug-04-26

Aug-04-2604:08PM

Williams Companies Inc (WMB) (Q2 2026) Earnings Call Highlights: Raises Guidance and Boosts Long-Term Growth Target to 11% CAGRgurufocus.com

Jul-30-26

Jul-30-2604:15PM

CooperCompanies Announces Release Date for Third Quarter 2026globenewswire.com

12:02AM

MGM Resorts International (MGM) (Q2 2026) Earnings Call Highlights: Record Revenue and Digital Growth Amidst Las Vegas Challengesgurufocus.com

Jul-27-26

Jul-27-2608:53PM

3 Cash-Producing Stocks We Find RiskyYahoo

Jul-21-26

Jul-21-2610:41AM

Why The Cooper Companies (COO) is a Top Value Stock for the Long-Termzacks.com

Jul-16-26

Jul-16-2604:54PM

Reasons to Retain Cooper Companies Stock in Your Portfolio for NowYahoo

Jul-10-26

Jul-10-2605:26AM

Chipotle's COO uses team dinners to spot potential leaders. These are the 4 qualities he looks for.businessinsider.com

Jul-08-26

Jul-08-2611:54AM

Citigroup Maintains Neutral on Cooper Companies, Raises Price Target to $76Benzinga

Jul-06-26

Jul-06-2607:11PM

SEC Names JPMorgan Veteran Paul Knight as COOpymnts.com

Jul-03-26

Jul-03-2611:14AM

2 Momentum Stocks to Consider Right Now and 1 We Turn DownYahoo

Jul-02-26

Jul-02-2608:32PM

The Cooper Companies Inc (COO) Shares Surge 3.1% -- What GF Score of 84 Tells Investorsgurufocus.com

Jul-01-26

Jul-01-2607:30AM

New Era Energy & Digital Announces Leadership Transition to Support Next Phase of Execution and Growthglobenewswire.com

Jun-29-26

Jun-29-2610:46AM

Here's Why The Cooper Companies (COO) is a Strong Growth Stockzacks.com

Jun-26-26

Jun-26-2605:50PM

Stifel Backs Cooper Companies (COO) as CooperSurgical Sale Talks ProgressYahoo

Jun-23-26

Jun-23-2609:12AM

3 of Wall Street’s Favorite Stocks That Concern UsYahoo

Company

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 10/31/2025	FY 2024 10/31/2024	FY 2023 10/31/2023	FY 2022 10/31/2022	FY 2021 10/31/2021	FY 2020 10/31/2020	FY 2019 10/31/2019	FY 2018 10/31/2018
Total Revenue	4,231	4,092	3,895	3,593	3,308	2,923	2,431	2,653	2,533
Cost of Goods Sold Incl. D&A	1,507	1,610	1,300	1,235	1,169	967	896	897	901
Gross Profit	2,723	2,483	2,596	2,358	2,140	1,956	1,535	1,757	1,632
Selling, General and Administrative Excl. Other	1,907	1,628	1,534	1,501	1,342	1,211	993	997	973
Research and Development	173	172	155	137	110	93	93	87	85
Other Operating Expense	145	0	201	187	180	146	137	145	147
Operating Income	498	683	706	533	508	506	312	547	403
Interest Expense	92	100	114	105	57	23	37	68	83
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	9	-16	-9	-15	25	9	-8	-1	12
Net Income Before Taxes	413	567	582	413	475	492	267	477	332
Income Taxes	177	192	190	119	90	-2,453	28	11	192
Consolidated Net Income	236	375	392	294	386	2,945	238	467	140
Net Income From Continuing Operations	236	375	392	294	386	2,945	238	467	140
Net Income	236	375	392	294	386	2,945	238	467	140
EPS (Recurring)	1.18	1.88	1.97	1.49	1.96	59.73	4.86	9.47	2.85
EPS (Basic, Before Extraordinaries)	1.18	1.88	1.97	1.49	1.96	59.73	4.86	9.47	2.85
EPS (Diluted)	1.18	1.87	1.96	1.48	1.94	59.07	4.81	9.32	2.81
EBITDA	866	1,053	1,072	886	879	824	590	826	690
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	63.30	37.39	53.41	52.66	35.23	1.76	16.58	7.81	22.98
Price To Sales Ratio	3.44	3.42	5.35	4.30	4.07	7.02	6.43	5.40	5.00
Gross Margin	64.36	60.68	66.65	65.63	64.69	66.92	63.14	66.23	64.43
Operating Margin	11.77	16.69	18.13	14.83	15.36	17.31	12.83	20.62	15.91
Net Margin	5.58	9.16	10.06	8.18	11.67	100.75	9.79	17.60	5.53
Shares Outstanding	195	200	199	198	197	197	196	197	196
Market Capitalization	14,565	13,982	20,831	15,432	13,465	20,533	15,633	14,332	12,658
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rosebrough Walter M Jr	Director	Apr 01 '26	Option Exercise	0.00	832	0	832	Apr 21
Carbone Barbara	Director	Apr 01 '26	Option Exercise	0.00	3,050	0	3,050	Apr 06
MADDEN TERESA S	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	15,679	Apr 06
Lucchese Cynthia L	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	12,767	Apr 06
Kurzius Lawrence Erik	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	11,099	Apr 06
Rivas Maria	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	3,322	Apr 06
Jay Colleen	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	39,907	Apr 06
WEISS ROBERT S	Director	Apr 01 '26	Option Exercise	0.00	3,654	0	292,599	Apr 06
Jay Colleen	Director	Jan 12 '26	Option Exercise	39.40	7,064	278,322	36,585	Jan 14
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '26	Option Exercise	0.00	12,887	0	76,007	Jan 12
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '26	Option Exercise	0.00	3,528	0	10,430	Jan 12
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '26	Option Exercise	0.00	11,518	0	29,837	Jan 12
White Albert G III	President & CEO	Jan 08 '26	Option Exercise	0.00	18,340	0	254,491	Jan 12
Sheffield Holly R	President, CSI	Jan 08 '26	Option Exercise	0.00	8,050	0	47,102	Jan 12
Lucchese Cynthia L	Director	Dec 22 '25	Buy	84.06	1,784	149,963	9,445	Dec 23

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.